Synthesis and In-Vitro Antimicrobial Activity of 4-(Piperazin-1-Ylcarbonyl) Aniline – An Amide Derivative of P-Aminobenzoic Acid
Swapna S Kulkarni1, AP Mehere2 and Priyank A Shenoy1*
1Alard College of Pharmacy, Sr.no 50, Marunje, Rajiv Gandhi Infotech Park, Pune-411057, Maharashtra, India.
Sharad Pawar College of Pharmacy, Wanadongari, Nagpur, Maharashtra, India.
*Corresponding Author E-mail: priyank.shenoy@rediffmail.com
ABSTRACT
An amide derivative of P-aminobenzoic acid (PABA) has been synthesized from piperazine by initial conversion of PABA into its hydrochloride salt for protection of amino group from self-polymerization. The compound identity has been characterized by Melting point, Elemental Analysis, TLC, UV-Visible spectroscopy, IR spectroscopy and NMR spectroscopy. The antibacterial activity of the compound has been studied against E.coli, S.aureus, B.subtilis and P.aeruginosa using tetracycline as a standard. Antifungal activity of the compound has been studied against C.albicans and A.niger using clotrimazole as a standard. The synthesized compound has been found to possess significant antibacterial and antifungal activities as compared to the standard drugs used.
KEYWORDS: Amide derivative, PABA, Self-Polymerization, Antibacterial, Antifungal.
INTRODUCTION:
The present work deals with the synthesis of 4-(Piperazin-1-ylcarbonyl)aniline from PABA and study of its antibacterial and antifungal activities. PABA is an essential nutrient for some bacteria and is sometimes called as Vitamin Bx or Vitamin H. It is an intermediate in bacterial synthesis of folate. PABA is used in sunscreen preparations since it can help protect the skin against UV-radiation. People suffering from vitiligo, over-pigmentation of skin, or without pigment in some spots have reported an improvement of the skin after more PABA was ingested1-2. The various compounds related to PABA have been found to possess useful pharmaceutical activities like antibacterial, antifungal3-4, antitubercular5-7, anthelmintic8-9, antitumor10-13. Being encouraged by these observations work was planned to synthesize and study the antimicrobial activity of the given amide derivative of PABA.
Method for Synthesis:
p-aminobenzoic acid (5 g, 0.025 mol) was boiled in concentrated hydrochloric acid (50 ml) to prepare the hydrochloride salt of p-aminobenzoic acid. It was dried on calcium chloride in dessicator. Hydrochloride salt of p-aminobenzoic acid was dissolved in dry pyridine(10 ml) in a conical flask. This solution was allowed to stand at 00 to 50 C for about 30 mins. Thionyl chloride (3ml) was added dropwise (Solution A).
Simultaneously; in another conical flask the solution of amine to be substituted was prepared (B).
Solution (B) and (A) was added equimole. The mixture was allowed to stand for 30 mins at room temperature and then poured into acidic (HCl) crushed ice. The separated dye was filtered using suction and dried at room temperature. The dye was recrystallized from Dimethylsulfoxide and stored over calcium chloride in a dessicator.
Yield: 69%
General Features of One Pot Synthesis:
1) It requires lesser time.
2) In this process, hydrochloride salt of PABA is converted into its corresponding acid chloride and then substituted with desired amines.
3) The reaction is temperature specific. The ideal temperature condition should be 0-5o c.
4) Pyridine is used as a solvent medium which acts as a base to drive the equilibrium in the formation of amide from amine and acid chloride.
Mechanism of Reaction:
Schotten-Baumann Reaction:
The use of added base is to drive the equilibrium in the formation of amides from amines and acid chlorides. The acylation of amines with carboxylic acid chlorides leads to the production of one equivalent acid, which will form a salt with unreacted amine and diminish the yield. The addition of an additional equivalent of base to neutralise this acid is a way to optimise the conditions.
In general, the use of biphasic aqueous basic conditions is often named "Schotten-Baumann conditions".
PROPOSED STRUCTURE OF THE COMPOUND
4-(PIPERAZIN-I-YLCARBONYL)ANILINE
CHARACTERIZATION:
1. Melting Point (mp):
401-404 0 C
2. Thin Layer Chromatography (TLC):
Solvent system used – DMSO: benzene: water in the concentration of 7:2:1.
|
Compound |
Rf value |
|
Test |
0.56 |
3. Ultraviolet-Visible(Uv) Spectroscopy:
The synthesized compound was analysed using dimethyl sulfoxide as a solvent on shimadzu 1700 UV-Visible Spectrophotometer.
|
Compound |
λmax |
|
Test |
322 |
4. Rotational And Vibrational (IR) Spectroscopy:
IR spectra of the compound was recorded using KBr pellets on FTIR –8100 S.
PEAK TABLE
|
Sr. No. |
Wave Number (cm-1) |
Characteristic Absorption Peak Assignment |
|
A. |
3346 1505-1596 |
Hydrogen Chromophore: • Aromatic Stretching • C-C multiple bond stretching (aromatic)
|
|
B. |
2580-2840 |
Carbonyl (C=O amide) Stretching
|
|
C. |
3058 |
N-H Stretching (Primary amide)
|
|
D. |
763 |
C-Cl Stretching (Aromatic) |
5. Nuclear magnetic resonance (NMR) spectroscopy:
Spectra of the compound was recorded using chloroform as a solvent on Varian Mercury YH-300 spectrophotometer at National Chemical Laboratory, Pune.
BIOLOGICAL SCREENING:
1. ANTIBACTERIAL ACTIVITY (in vitro):
The preliminary in vitro antibacterial activity of compound was studied against four different species viz. Escherichia coli, Staphylococcus aureus, Pseudomonas aeruginosa and Bacillus subtilis by cylinder plate or cup-plate method. The method depends on the diffusion of drug from cup through the solidified agar layer of a petridish to an extent such that growth of the inoculated microorganism is prevented entirely in a circular area (known as zone of inhibition) around the cup containing solution of the compound under the test.
PROCEDURE:
Method : Cup Plate Method,
Media : Nutrient agar media,
Solvent : 70% DMSO,
Concentration: 100µg/ml,
Condition: 24 h at 32- 38° (depending on the bacterial species)
Standard: Tetracycline (100μg/ml).
IR Spectra of the Compound
NMR Spectra of the Compound
STEP-1 Conversion of PABA into their hydrochloride salt
STEP-2 Conversion of salt into acid chloride
STEP-3 Substitution with amines
2. ANTIFUNGAL ACTIVITY (in vitro):
The preliminary in vitro antifungal activity of the compound was studied against two different species viz. Candida albicans and Aspergillus niger by cylinder plate or cup-plate method.
PROCEDURE:
Method : Cup Plate Method
Media : Antifungal drug assay medium
Solvent : 70% DMSO
Concentration: 100µg/ml
Condition: 48 h at 37°
Standard: Clotrimazole (100μg/ml
RESULTS AND DISCUSSION:
From PABA the test compound was synthesized as per the
given scheme and FTIR, NMR studies were carried out. The successful synthesis
of the compound was achieved with 69% yield. The purity and homogeneity of the
compound was checked and ascertained by TLC as the compound was found to give
single spot. According to the results obtained, the compound was found to
possess significant antibacterial and antifungal activities as compared to the
standards.
ANTIBACTERIAL ACTIVITY DATA OF COMPOUND
Compound |
Average Zone of Inhibition (mm) |
|||
|
E. coli |
S. aureus |
B. subtilis |
P. aeruginosa |
|
|
Tetracycline |
27 |
30 |
28 |
20 |
|
DMSO |
-- |
-- |
-- |
--- |
|
Test |
15 |
27 |
17 |
11 |
ANTIFUNGAL ACTIVITY DATA OF COMPOUND
|
Compound |
Average Zone of Inhibition (mm) |
|
|
C. albicans |
A. niger |
|
|
Clotrimazole |
19 |
15 |
|
DMSO |
-- |
-- |
|
Test |
11 |
13 |
CONCLUSION:
The results of characterization parameters were in conformity with the structure assigned. Structural similarity of the compound with the existing drugs is responsible for the above mentioned activities. More derivatives can be prepared using amino acids, alcohols by this method and can be tested for antiviral, antifungal, antimalarial and other relevant pharmacological activities.
REFERENCES:
1) Duggan D E, Hooke K F, Risley E A, Shen T Y, Arman C G; J. Pharmacol. Exp.201, 1977, 8-10.
2) Bodor N, Simpkins J W, Science, Washington D.C., 1983, 221, 65.
3) Turcheilli R F, Lamy-Freud M T, Hirata I Y, Juliano L, Ito A S; Biophys. Chem, 1998, 73, 217.
4) Larsen A A, Moore C H, Sprague J, Cloke B, Moss J, Hppe J; Am. Chem Soc., 1956, 78, 3210.
5) Kotler-Brajtburg et al.; Roczniki Chem., 1962, 36, 763.
6) Parimoo P; A Textbook of Medicinal Chemistry, CBS Publication, New Delhi, 337.
7) Budawari S; The Merck Index, Merck and Co. Inc, New Jersey, 1989, 191, 412.
8) Mohan R R, Mishra V S; Indian Drugs, 1986, 418.
9) Mahadevan K M, Vaidya V P; Indian J of Pharm. Sci., 2003, 128.
10) Kawathekar N, Chaturvedi S C; Indian J of Pharm. Sci., 1998, 346.
11) Sidelman U G, Christansen F, Krougl L; Chem. Abstr., 1978, 265.
12) Cocco M T, Congin C, Lillin V, Onnis V; Bioorg. Medichem. Lett., 2004, 5787.
13) Kadam S S, Mahadik K R, Bothara K G; Principles of Medicianal Chemistry, Nirali Prakashan, Pune, 2005 Vol.1, 150.
14) Block J H , Beale J M; Wilson and Gisvold’s Textbook Of Organic Medicinal and Pharmaceutical Chemistry, Lippincott-Raven Publishers, New York, 11th edn.,2004, 1, 260.
15) David A W, Thomas L L, William M; Foye’s Principles Of Medicinal Chemistry, Lippincott William and Wilkins, 5th edn., 2002, 12.
16) Thomas G; Drug Discovery and Deign Historical Outline, John Wiley and Sons, 2002, 3.
17) Donald A J; Burger’s Medicinal Chemistry and Drug Discovery, Wiley Interscience-A John Wiley and Sons, Inc., Publication, 6th edn.3, 2003, 2.
18) Gennaro A R; Remington The Science and Practice of Pharmacy, Lippincott Williams and Wilkins, Philadephia, 2000, 1214
19) Tripathi K D; Essentials of Medical Pharmacology, 4th edn., Jaypee Brothers, New Delhi, 1998, 591.
20) Verma R S, Rastogi N, Singh A P; Indian J of Heterocyclic Chemistry, 2003, 131.
21) Furniss B S, Hannaford A J, Rogers V, Smith P W, Tatchell A R; Vogel’s Textbook of Practical Organic Chemistry, Longman Group Ltd., Harlow, 1986, 497,677.
22) Beckett A H, Stenlake J B; Practical Pharmaceutical Chemistry, CBS Publishers and Distributors: New Delhi, 2004, 162.
23) Willard H H, Merritt Jr L L, Dean J A, Settle Jr F A; Instrumental Methods of Analysis, CBS Publishers and Distributors: New Delhi, 1986, 292.
24) Morrison R T, Boyd R N; Organic Chemistry, Prentice Hall of India, New Delhi,2000, 600.
25) Govt. of India, Ministry of Health and Family Welfare, Indian Pharmacopeia, The Controller of publication:Delhi, 1996, Vol.2, A-100.
Received on 17.06.2009 Modified on 02.07.2009
Accepted on 08.07.2009 © AJRC All right reserved
Asian J. Research Chem. 2(3): July-Sept., 2009, page 300-303